| Safety and efficacy of NVX-CoV2373 Covid-19 vaccine PT Heath, EP Galiza, DN Baxter, M Boffito, D Browne, F Burns, ... New England Journal of Medicine 385 (13), 1172-1183, 2021 | 943 | 2021 |
| Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial HJL Heerspink, HH Parving, DL Andress, G Bakris, R Correa-Rotter, ... The Lancet 393 (10184), 1937-1947, 2019 | 489 | 2019 |
| Serum phosphorus levels associate with coronary atherosclerosis in young adults RN Foley, AJ Collins, CA Herzog, A Ishani, PA Kalra Journal of the American Society of Nephrology 20 (2), 397-404, 2009 | 450 | 2009 |
| Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis PA Kalra, H Guo, AT Kausz, DT Gilbertson, J Liu, SC Chen, A Ishani, ... Kidney international 68 (1), 293-301, 2005 | 421 | 2005 |
| Intravenous iron in patients undergoing maintenance hemodialysis IC Macdougall, C White, SD Anker, S Bhandari, K Farrington, PA Kalra, ... New England Journal of Medicine 380 (5), 447-458, 2019 | 417 | 2019 |
| Study of Heart and Renal Protection (SHARP): randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease Sharp Collaborative Group American heart journal 160 (5), 785-794. e10, 2010 | 410 | 2010 |
| Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study RN Foley, AJ Collins, A Ishani, PA Kalra American heart journal 156 (3), 556-563, 2008 | 360 | 2008 |
| Serum phosphate and mortality in patients with chronic kidney disease H Eddington, R Hoefield, S Sinha, C Chrysochou, B Lane, RN Foley, ... Clinical Journal of the American Society of Nephrology 5 (12), 2251-2257, 2010 | 319 | 2010 |
| Renal dysfunction accompanying oral creatine supplements P Greenhaff The Lancet 352 (9123), 233, 1998 | 304 | 1998 |
| The unrecognized prevalence of chronic kidney disease in diabetes RJ Middleton, RN Foley, J Hegarty, CM Cheung, P McElduff, JM Gibson, ... Nephrology Dialysis Transplantation 21 (1), 88-92, 2006 | 278 | 2006 |
| Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure P MacDowall, PA Kalra, DJ O'Donoghue, S Waldek, H Mamtora, K Brown The Lancet 352 (9121), 13-16, 1998 | 254 | 1998 |
| Iron management in chronic kidney disease: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference IC Macdougall, AJ Bircher, KU Eckardt, GT Obrador, CA Pollock, ... Kidney international 89 (1), 28-39, 2016 | 247 | 2016 |
| Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis AF Malone, PJ Phelan, G Hall, U Cetincelik, A Homstad, AS Alonso, ... Kidney international 86 (6), 1253-1259, 2014 | 239 | 2014 |
| High-risk clinical presentations in atherosclerotic renovascular disease: prognosis and response to renal artery revascularization J Ritchie, D Green, C Chrysochou, N Chalmers, RN Foley, PA Kalra American journal of kidney diseases 63 (2), 186-197, 2014 | 211 | 2014 |
| Effects of sacubitril/valsartan versus irbesartan in patients with chronic kidney disease: a randomized double-blind trial R Haynes, PK Judge, N Staplin, WG Herrington, BC Storey, A Bethel, ... Circulation 138 (15), 1505-1514, 2018 | 202 | 2018 |
| New insights into the epidemiologic and clinical manifestations of atherosclerotic renovascular disease PJ Conlon, E O'Riordan, PA Kalra American journal of kidney diseases 35 (4), 573-587, 2000 | 195 | 2000 |
| Sudden cardiac death in hemodialysis patients: an in-depth review D Green, PR Roberts, DI New, PA Kalra American Journal of Kidney Diseases 57 (6), 921-929, 2011 | 194 | 2011 |
| Joint modelling of repeated measurement and time-to-event data: an introductory tutorial Ö Asar, J Ritchie, PA Kalra, PJ Diggle International journal of epidemiology 44 (1), 334-344, 2015 | 184 | 2015 |
| A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease JR Wright, ES Ala'a, C Cheung, S Waldek, DJ O'Donoghue, RN Foley, ... American journal of kidney diseases 39 (6), 1153-1161, 2002 | 174 | 2002 |
| Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded … PR Kalra, JGF Cleland, MC Petrie, EA Thomson, PA Kalra, IB Squire, ... The Lancet 400 (10369), 2199-2209, 2022 | 167 | 2022 |
